7th European Conference on Schizophrenia Research

30 SCIENTIFIC PROGRAMME | Friday, 27 September 2019 S-18 SYMPOSIA 16:30–18:00 Plenary The aberrant Salience-hypothesis and the clinical high-risk state of schizophrenia Chairs: J. Klosterkötter, Cologne, Germany A. Heinz, Berlin, Germany S-18-001 Origin of the Salience hypothesis and its pres- ent state of development A. Heinz, Berlin, Germany S-18-002 Neurobiological basics of Salience in the psy- chosis spectrum J. Kambeitz, Cologne, Germany S-18-003 The high-risk state for psychoses: What fea- tures might result from salience aberrations? F. Schultze-Lutter, Düsseldorf, Germany S-18-004 Synthesis capacity in clinical high-risk states R. McCutcheon, London, United Kingdom O. D. Howes S-19 SYMPOSIA 16:30–18:00 Harvard Targeting patients‘ specific brain networks for psychotic symptoms: Moving towards precision and personalized rTMS Chairs: J. Foucher, Strasbourg, France S. Walther, Bern, Switzerland S-19-001 Repetitive transcranial magnetic stimulation in drug-resistant hallucinations: Impact of treatment response on striatal GABA and glx levels A. Leroy, Lille, France M. Edjlali-Goujon, D. Roman, R. Lopes, P. Thomas, R. Jardri S-19-002 Are all hallucinated patients tuned to the same frequency? Low vs. High-frequency-rTMS S. Dollfus, Caen, France S-19-003 rTMS in abulia: From brain imaging to precision medicine S. Walther, Bern, Switzerland S-19-004 Personalized rTMS to improve chronic and treatment resistant catatonias – a proof of concept J. Foucher, Strasbourg, France C. de Billy, O. Mainberger, L. Jeanjean, B. Schorr, J. Clauss, F. Berna, A. Obrecht